Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
CML: The good, the better, and the difficult choices
Jorge Cortes
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CML: The good, the better, and the difficult choices'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Myeloid Leukemia
100%
Difficult Choices
100%
Initial Treatment
50%
Cooperative Group
50%
Dasatinib
50%
Imatinib
50%
Group Reports
50%
Medicine and Dentistry
Myeloid Leukemia
100%
Dasatinib
100%
Imatinib
100%
Chronic Myelogenous Leukemia
100%
Pharmacology, Toxicology and Pharmaceutical Science
Dasatinib
100%
Chronic Myeloid Leukemia
100%
Imatinib
100%
Myeloid Leukemia
100%